Neovasc to present at Lazard Capital Markets 8th Annual Healthcare Conference

VANCOUVER, Nov. 8, 2011 /CNW/ - Neovasc Inc. (TSXV: NVC) today announced that chief executive officer Alexei Marko will present at the upcoming Lazard Capital Markets 8th Annual Healthcare Conference at 4:00 PM EST on November 15, 2011. The conference will be held at the Pierre Hotel in New York City.

The company's presentation will be webcast live. It can be accessed at the Investors section of the Neovasc website at or at An archived version of the webcast will be available for at least 30 days after the conference.

For more information about the Lazard 8th Annual Healthcare Conference, visit
About Neovasc Inc.
Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina, the Tiara™ technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. For more information, visit

SOURCE Neovasc Inc.

For further information:

Corporate contact:
Neovasc Inc.
Chris Clark
604 249-4138

U.S. media & investor contact:
GendeLLindheim BioCom Partners
Barbara Lindheim
212 584-2276



Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.